A validated stability-indicating liquid-chromatographic method for ranitidine hydrochloride in liquid oral dosage form
- PMID: 21773068
- PMCID: PMC3134857
- DOI: 10.3797/scipharm.1101-06
A validated stability-indicating liquid-chromatographic method for ranitidine hydrochloride in liquid oral dosage form
Abstract
A selective, specific and stability-indicating gradient reverse phase high-performance liquid chromatographic (HPLC) method was developed for the determination of Ranitidine in presence of its impurities, forced degradation products and placebo substances such as saccharide and parabens. Ultraviolet detection was performed at 230 nm. Separate portions of the drug product and ingredients were exposed to stress conditions to induce oxidative, acidic, basic, hydrolytic, thermal and photolytic degradation. Ranitidine was found to degrade significantly at acidic, basic and oxidative stress conditions but was stable at heat and humidity. The developed method was validated as per International Conference on Harmonization (ICH) guidelines. The method was validated over this range for (i) system suitability (ii) specificity, (iii) precision, (iv) limit of detection and limit of quantification, (v) linearity, (vi) accuracy, (vii) robustness. The method was found to be precise, accurate, linear and robust. The proposed method was successfully employed for estimation of Ranitidine impurities in pharmaceutical preparations.
Keywords: Impurities; Method development; Oral Solution; RP-HPLC; Ranitidine; Stability-indicating; Stress conditions.
Figures




Similar articles
-
UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.J Chromatogr Sci. 2012 Oct;50(9):810-9. doi: 10.1093/chromsci/bms075. Epub 2012 Jun 1. J Chromatogr Sci. 2012. PMID: 22661461
-
Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.J Pharm Biomed Anal. 2010 Nov 2;53(3):483-9. doi: 10.1016/j.jpba.2010.05.022. J Pharm Biomed Anal. 2010. PMID: 20646890
-
A novel validated stability indicating high performance liquid chromatographic method for estimation of degradation behavior of ciprofloxacin and tinidazole in solid oral dosage.J Pharm Bioallied Sci. 2013 Oct;5(4):298-308. doi: 10.4103/0975-7406.120082. J Pharm Bioallied Sci. 2013. PMID: 24302838 Free PMC article.
-
Choices of chromatographic methods as stability indicating assays for pharmaceutical products: A review.Heliyon. 2021 Mar 27;7(3):e06553. doi: 10.1016/j.heliyon.2021.e06553. eCollection 2021 Mar. Heliyon. 2021. PMID: 33855234 Free PMC article. Review.
-
Mini Review on Forced Degradation Studies on Anti-Epileptic Drugs and Beyond.J Chromatogr Sci. 2023 Jul 9;61(6):585-604. doi: 10.1093/chromsci/bmac070. J Chromatogr Sci. 2023. PMID: 35980304 Review.
References
-
- British Pharmacopoeia. The Stationery Office; London: 2007.
-
- United States Pharmacopeia. 31st edn. The convention 12601; Rockville: 2008. p. 3477.
LinkOut - more resources
Full Text Sources